Form 4 for CDNA CareDx, Inc.
Accepted 2021-08-09 00:00:00 ET · period of report 2021-08-05 · accession 0001217234-21-000196 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-09 | 2021-08-05 | CDNA | Maag Peter | Executive COB, Dir | M - OptEx | $11.36 | +4,958 | 354.3K | +1% | +$56.3K |
| DM | 2021-08-09 | 2021-08-05 | CDNA | Maag Peter | Executive COB, Dir | S - Sale+OE | $83.13 | -10.0K | 349.3K | -3% | -$831.3K |
| DM | 2021-08-09 | 2021-08-05 | CDNA | Maag Peter | Executive COB, Dir | M - OptEx | $11.36 | +4,958 | 10.8K | +85% | +$56.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-05 | M | A | 3,938 | $12.24 | 353,236 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-05 | M | A | 926 | $6.31 | 354,162 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-05 | M | A | 94 | $24.35 | 354,256 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-05 | S | D | 3,096 | $82.81 | 356,202 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.00 to $83.00, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 5 | Common | Common Stock | 2021-08-05 | S | D | 6,904 | $83.27 | 349,298 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.01 to $83.75, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2021-08-05 | M | A | 3,938 | $12.24 | 31,250 | D | $12.24 · — to 2028-06-29 | 3,938 Common Stock | (F5) 1/4th of the shares subject to the option vested on June 1, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2021-08-05 | M | A | 94 | $24.35 | 62,253 | D | $24.35 · — to 2030-02-03 | 94 Common Stock | (F7) 1/4th of the shares subject to the option vested on January 29, 2021 and 1/48th of the shares subject to the option vest monthly thereafter. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2021-08-05 | M | A | 926 | $6.31 | 10,792 | D | $6.31 · — to 2028-01-19 | 926 Common Stock | (F6) 1/4th of the shares subject to the option vested on January 19, 2019 and 1/48th of the shares subject to the option vest monthly thereafter. |